Tags : AdaptVac

Biotech COVID-19

Bavarian Nordic Collaborates with AdaptVac to Advance COVID-19 Vaccine Program

Shots::stoohthShots: Bavarian signs an exclusive head of terms agreement with AdaptVac, (a joint venture of ExpreS2ion and NextGen Vaccines) to license AdaptVac’s capsid VLP-based SARS-CoV-2 subunit vaccine. A final agreement is expected to be consummated within the next two months Following the execution of the final license agreement, AdaptVac to receive upfront, development & commercial […]Read More